An Intervention Program to Reduce to the Risk of Persistent Symptoms After Concussion

November 2, 2018 updated by: Noah Silverberg, University of British Columbia

Prevention of Persistent Post-concussion Syndrome With Cognitive-behavioural Therapy in At-risk Patients

This study investigates how well a new therapy program prevents persistent symptoms (e.g., headaches, fatigue, irritability, etc.) after concussion. The program involves examining beliefs about concussion and learning healthy coping strategies, and is completed with the first three months post-injury.

Study Overview

Detailed Description

Although the majority of patients with mild traumatic brain injury (MTBI) experience complete recovery within three months, a sizeable group continues to report frequent and severe symptoms such as headaches, fatigue, difficulty concentrating, forgetfulness, and irritability, in what is labeled persistent post-concussion syndrome (PCS). Persistent PCS is associated with vocational, recreational, and social disability. Early education and reassurance (treatment as usual) is effective in general, but appears insufficient for this subgroup.

Recent research has identified risk factors for persistent PCS, including inaccurate illness beliefs, maladaptive coping behaviour, and emotional distress. The present study will evaluate the additive efficacy of a cognitive-behavioural therapy protocol designed to modify these risk factors, over and above treatment as usual.

Participants with MTBI will be recruited within six weeks of injury. Those identified as being at-risk for persistent PCS based on evidence-based criteria will receive treatment as usual and then be randomly assigned to receive either no further intervention or cognitive-behavioural therapy. We hypothesize that the group receiving cognitive-behavioural therapy will have fewer PCS symptoms and be less disabled at follow-up. We also hypothesize that compensation-seeking status will mitigate this improvement and that illness beliefs, coping behaviour, and emotional distress will mediate this improvement. A blinded rater will conduct the baseline and outcome assessments.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada
        • GF Strong Rehab Centre, 4255 Laurel Street

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Incurred head trauma within six weeks of study entry
  • Meet American Congress of Rehabilitation criteria for MTBI, documented by the referring/treating physician
  • Subjective report at least one symptom attributable to head trauma
  • English as preferred language for communication
  • Considered at-risk for persistent PCS based on prognostic model from Whittaker et al. (2007)

Exclusion Criteria:

  • Medical documentation of skull fracture or acute intracranial abnormality on neuroimaging, consistent with "mild-complicated" TBI
  • Self-reported history of a neurological disorder (including prior MTBI within the past six months)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: I
Treatment as usual
Single session with early intervention coordinator for assessment, education about mild traumatic brain injury, and recommendations for symptom management.
Experimental: II
Treatment as usual + cognitive-behavioural therapy
Single session with early intervention coordinator for assessment, education about mild traumatic brain injury, and recommendations for symptom management.
6-session manualized cognitive-behavioural therapy protocol designed to prevent persistent post-concussion syndrome

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
PCS symptoms (Rivermead Postconcussion Symptoms Questionnaire)
Time Frame: Pre-intervention and three months later
Pre-intervention and three months later
Functional disability (Mayo-Portland Participation Index)
Time Frame: Pre-intervention and three months later
Pre-intervention and three months later

Secondary Outcome Measures

Outcome Measure
Time Frame
Illness beliefs (Illness Perceptions Questionnaire-Revised)
Time Frame: Pre-intervention and three months later
Pre-intervention and three months later
Coping style (PCS Coping Inventory)
Time Frame: Pre-intervention and three months later
Pre-intervention and three months later
Psychological distress (Hospital Anxiety and Depression Scale) )
Time Frame: Pre-intervention and three months later
Pre-intervention and three months later
Pain (Brief Pain Scale)
Time Frame: Pre-intervention and three months later
Pre-intervention and three months later
Psychiatric diagnosis (MINI International Neuropsychiatric Interview)
Time Frame: Pre-intervention and three months later
Pre-intervention and three months later

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Noah Silverberg, PhD, University of British Columbia
  • Study Director: Brad Hallam, University of British Columbia
  • Study Director: Alice Rose, Vancouver Coastal Health
  • Study Director: Heather Underwood, University of British Columbia
  • Study Director: Allen Thornton, Simon Fraser University
  • Study Director: Kevin Whitfield, Simon Fraser University
  • Study Director: Maureen Whittal, University of British Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2009

Primary Completion (Actual)

July 1, 2012

Study Completion (Actual)

October 1, 2012

Study Registration Dates

First Submitted

May 4, 2009

First Submitted That Met QC Criteria

May 5, 2009

First Posted (Estimate)

May 6, 2009

Study Record Updates

Last Update Posted (Actual)

November 6, 2018

Last Update Submitted That Met QC Criteria

November 2, 2018

Last Verified

November 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Traumatic Brain Injury

Clinical Trials on Treatment as usual

Subscribe